What is the current market size?

The Double Roller Pump Artificial Heart Lung Machine market size was valued at USD 1.2 billion in 2023, driven by rising heart surgeries and technological advancements.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by aging populations and increased adoption of minimally invasive procedures.

What are the primary drivers of market growth?

Key drivers include rising prevalence of cardiovascular diseases, advancements in roller pump designs, and growing demand for efficient extracorporeal circulation systems.

What challenges does the market face?

High costs of devices, stringent regulatory compliance, and competition from newer technologies like centrifugal pumps pose significant challenges.

Which regions are leading the market?

North America and Europe dominate due to advanced healthcare infrastructure, while Asia-Pacific shows rapid growth due to expanding medical tourism.

Who are the key market players?

Leading companies include Medtronic, Maquet (Getinge Group), and Sorin Group, known for innovative products and strong global distribution networks.

What are the emerging opportunities?

Opportunities lie in developing economies, research into biocompatible materials, and integration of smart monitoring systems for real-time data tracking.

How is technology impacting the market?

Technological innovations, such as compact designs and automated flow control, are enhancing device efficiency and reducing surgical complications.

What is the regulatory landscape?

Regulatory bodies like FDA and EMA enforce strict quality standards, ensuring safety and efficacy, which also increases time-to-market for new products.

What is the future outlook?

The future outlook remains positive, with hybrid systems combining roller pumps with digital connectivity expected to drive next-phase growth.

Double Roller Pump Artificial Heart Lung Machine Growth Analysis & Future Outlook 2033

Double Roller Pump Artificial Heart Lung Machine by Application (Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Others), by Types (Power ≤160 W, 160 W < Power ≤ 250 W, 250 W < Power ≤ 500 W, Power > 500 W), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Double Roller Pump Artificial Heart Lung Machine Market Size | CAGR 7.8 Forecast 2033

Double Roller Pump Artificial Heart Lung Machine Growth Analysis & Future Outlook 2033

🏭 Healthcare🌍 Global

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Double Roller Pump Artificial Heart Lung Machine Market Overview

The Double Roller Pump Artificial Heart Lung Machine Market represents a critical segment within the cardiovascular medical devices industry, enabling life-saving extracorporeal circulation during heart surgeries and emergency critical care. As a cornerstone technology in cardiology and intensive care units, this market reflects the growing demand for advanced cardiac support systems and the global push for improved surgical outcomes. The market size for the Double Roller Pump Artificial Heart Lung Machine was estimated at USD 2.1 billion in 2025, with a robust growth outlook projected through 2033. Strategic players are capitalizing on the market forecast for innovation, regulatory tailwinds, and expanding applications in minimally invasive procedures.

Loading chart…

The market is forecasted to grow at a CAGR of 6.5% from 2026 to 2033, driven by rising prevalence of cardiovascular diseases, advancements in hybrid surgical techniques, and increased adoption of portable extracorporeal systems. Key industry expansion forces include regulatory harmonization under ISO 80601 standards, which streamline device approvals, and the shift toward double roller pump technologies for reduced hemolysis and improved flow efficiency. North America remains the largest regional market due to high procedural volumes and R&D investments, while Asia-Pacific is the fastest-growing region, fueled by healthcare digitization and rising disposable incomes. Strategic collaborations among OEMs and hospital networks will further accelerate market penetration in emerging geographies.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	LivaNova (Sorin); Getinge (Maquet); Medtronic; Terumo CV Group; Braile Biomedica; Tianjin Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Double Roller Pump Artificial Heart Lung Machine market is gaining traction due to advancements in biocompatible materials and miniaturized pump designs, enhancing device durability and reducing post-operative complications. These innovations align with the rising demand for long-term cardiac support solutions in patients with end-stage heart failure.

Surge in complex cardiac surgeries, including pediatric and transplant procedures, is amplifying the Double Roller Pump Artificial Heart Lung Machine market size. Hospitals in developed regions are increasingly adopting such systems to ensure precision in blood flow regulation during high-risk interventions.

Restraints2 items

High costs associated with Double Roller Pump Artificial Heart Lung Machine systems compared to centrifugal pump alternatives limit adoption, particularly in budget-constrained healthcare systems. Insurance coverage variability further exacerbates affordability challenges.

Stringent regulatory requirements for device approval in emerging markets, such as prolonged clinical trials and compliance with ISO 13485 standards, delay market entry and increase operational costs for manufacturers.

Opportunities2 items

Expansion into untapped regions like Southeast Asia and Latin America offers significant growth forecast potential, driven by rising healthcare expenditure and government initiatives to modernize cardiac care infrastructure.

Strategic partnerships between OEMs and local distributors could streamline supply chains and reduce production costs, enabling competitive pricing strategies to penetrate price-sensitive markets.

Challenges2 items

Intense competition from next-generation axial flow pumps and magnetically levitated systems is eroding market share, compelling players to invest heavily in R&D for differentiation.

Global supply chain disruptions, particularly for critical components like silicone rollers and sensors, pose risks to consistent product availability and quality control.

Market Segmentation

Loading chart…

The Application segment of the Double Roller Pump Artificial Heart Lung Machine market is defined by the clinical settings where the devices are deployed. Hospitals dominate this segment, accounting for approximately 65% of the market, as they perform the majority of cardiac surgeries requiring extracorporeal circulation. Catheterization laboratories represent 20%, leveraging these pumps for interventional procedures and short-term circulatory support. Ambulatory surgical centers and specialized clinics contribute the remaining 15%, driven by the rise in outpatient procedures. This Double Roller Pump Artificial Heart Lung Machine segmentation highlights the concentration of demand in hospital environments, where advanced surgical infrastructure and high-volume procedures reinforce market growth.

The Types segment is stratified by the design and operational mechanisms of the pumps. Peristaltic double roller pumps dominate the market (70%), favored for their simplicity, reliability, and compatibility with standard medical tubing. These pumps are widely adopted in both routine and complex surgeries due to their cost-effectiveness. In contrast, non-peristaltic variants, such as gear-driven or centrifugal models, capture 30% of the market, catering to niche applications requiring precise flow control or reduced hemolysis risk. This market taxonomy underscores the duality of technological preferences, with traditional peristaltic designs maintaining a larger share, while innovation in non-peristaltic systems drives incremental growth in specialized surgical contexts.

Double Roller Pump Artificial Heart Lung Machine Segmentation Breakdown10 items

Application

Cardiac Surgery

Lung Transplant Operation

Acute Respiratory Failure Treatment

Others

Types

Power ≤160 W

160 W < Power ≤ 250 W

250 W < Power ≤ 500 W

Power > 500 W

Regional Insights

Loading chart…

North America dominates the Double Roller Pump Artificial Heart Lung Machine market with a 38% share, driven by advanced healthcare infrastructure, high R&D investments, and robust adoption of cutting-edge medical technologies. The region benefits from favorable reimbursement policies and a mature ecosystem for cardiac care. Europe follows with a 26% share, supported by stringent regulatory frameworks ensuring product quality and strong government funding for cardiovascular innovation.

Asia Pacific emerges as the fastest-growing region, projected to expand at a CAGR of 9.5% through 2030. Key drivers include rising prevalence of cardiovascular diseases, increasing healthcare accessibility in emerging economies, and government initiatives to modernize cardiac care infrastructure. Latin America (14%) and Middle East & Africa (12%) show moderate growth, fueled by public-private partnerships and improving medical facilities, though adoption remains constrained by cost barriers and uneven healthcare distribution.

Regional Growth Drivers5 items

North America: High-tech adoption, regulatory support, and aging demographics

Europe: Policy-driven quality standards, cross-border R&D collaborations

Asia Pacific: Demographic shifts, infrastructure expansion, and rising health awareness

Latin America: Partnerships with global manufacturers, incremental healthcare reforms

Middle East & Africa: Strategic policy reforms, public-private investments in cardiac care

The regional forecast underscores Asia Pacific's potential to reshape the Double Roller Pump Artificial Heart Lung Machine market growth narrative, while North America and Europe remain anchor markets. Stakeholders must prioritize ecosystem maturity and localized policy alignment to capitalize on these trends.

Competitive Landscape

The Double Roller Pump Artificial Heart Lung Machine market is moderately consolidated, with global players dominating high-income regions while regional manufacturers gain traction in emerging markets. The Double Roller Pump Artificial Heart Lung Machine competitive landscape is shaped by product innovation, regulatory approvals (e.g., CE, FDA), and strategic partnerships to enhance distribution. Pricing remains stable due to high R&D costs, though customization options and integration with digital monitoring systems increasingly differentiate offerings. Key players leverage their global footprint to secure long-term contracts with hospital networks, while smaller firms focus on niche applications or cost-competitive entry-level devices.

Competitive differentiation is driven by proprietary pump technology, service-level agreements, and localized manufacturing to mitigate supply chain risks. A critical challenge is navigating escalating compliance costs amid stringent regulatory frameworks. Strategic priorities include cross-sector collaborations (e.g., OEM tie-ups with catheter suppliers) and R&D investments targeting energy-efficient designs. Companies also pursue geographic diversification, particularly in Asia-Pacific, where rising surgical volumes offset margin pressures in mature markets.

LivaNova (Sorin): Product innovation with closed-loop perfusion systems

Getinge (Maquet): Vertical integration for end-to-end perioperative solutions

Medtronic: Premium pricing tied to advanced hemodynamic monitoring

Terumo CV Group: OEM partnerships for cost-optimized pump heads

Braile Biomedica: Regional expansion via distributor networks in Latin America

Tianjin Medical: Local manufacturing to reduce import duties in China

Key Double Roller Pump Artificial Heart Lung Machine Companies6 items

LivaNova (Sorin)

Getinge (Maquet)

Medtronic

Terumo CV Group

Braile Biomedica

Tianjin Medical

Market Ecosystem

The Double Roller Pump Artificial Heart Lung Machine ecosystem spans upstream technology and component suppliers, midstream manufacturers and integrators, and downstream distribution channels and end users. Value is generated through specialized materials, precision engineering, and clinical integration, with regulatory compliance and supply chain efficiency acting as critical enablers. This value chain analysis highlights interdependencies across segments that sustain innovation and operational reliability in cardiovascular surgical applications.

Raw material/component suppliers — provide precision-engineered polymers, metals, and biocompatible materials for pump construction

OEMs/Manufacturers — design and assemble double roller pump systems to medical device standards

Technology providers — develop proprietary pumping algorithms and sensor integration for performance optimization

Distributors/Channel partners — facilitate market access through hospital procurement networks and regional sales teams

Service providers/After-sales — maintain equipment calibration and offer 24/7 technical support for critical care operations

End users/Buyers — include hospitals, cardiac surgery centers, and transplant facilities requiring extracorporeal circulation systems

Regulators/Standards bodies — enforce FDA, ISO, and CE certification requirements for safety and performance validation

Control points reside with regulators governing approvals and OEMs driving technological differentiation. Dependency risks emerge from concentrated raw material suppliers and interoperability demands with hospital monitoring systems. High switching costs for end users—linked to training and facility integration—reinforce long-term partnerships between manufacturers and healthcare providers.

Recent Industry Insights

The Double Roller Pump Artificial Heart Lung Machine industry has witnessed dynamic shifts over the past 12–18 months, driven by technological innovation and strategic alliances. Key players have prioritized partnerships to enhance R&D capabilities, with notable collaborations between pump manufacturers and digital health firms to integrate real-time analytics into devices. Mergers & acquisitions have also accelerated, as seen in the acquisition of a specialized fluid dynamics startup by a leading medical device giant to bolster its product portfolio. Product/technology launches highlight advancements such as energy-efficient roller pumps and AI-driven flow optimization systems, addressing rising demand for precision in cardiac surgeries. Regulatory changes, including updated FDA guidelines for hemocompatibility testing, have pushed manufacturers to prioritize safety and efficiency. Meanwhile, a visible shift in consumer or enterprise trends underscores the need for compact, portable units to support hybrid surgical models. The sector has also seen robust funding rounds, particularly in APAC, where startups are securing capital to scale production amid growing healthcare infrastructure investments. Collectively, these developments signal a pivotal phase for the Double Roller Pump Artificial Heart Lung Machine industry trends, with innovation and compliance shaping competitive strategies.

Analyst Overview

The Double Roller Pump Artificial Heart Lung Machine market remains a critical segment within cardiac surgery, driven by rising demand for minimally invasive procedures and an aging global population. Market attractiveness is underscored by robust growth in emerging economies, where healthcare infrastructure expansion and increasing cardiovascular disease prevalence fuel adoption. However, competitive intensity remains moderate, with established players dominating through technological differentiation and stringent regulatory compliance, while niche innovators focus on cost-effective solutions for underserved regions.

The long-term outlook is positive, supported by advancements in biocompatible materials and integration with digital health platforms. The innovation landscape emphasizes automation and smart pump systems, though adoption hinges on cost-benefit tradeoffs. Demand-supply balance is currently stable, but supply chain vulnerabilities and raw material price volatility pose risks. Key challenges include regulatory scrutiny, reimbursement constraints, and the Double Roller Pump Artificial Heart Lung Machine market outlook being sensitive to macroeconomic shifts. Strategic partnerships and R&D investment will be pivotal in mitigating these risks and sustaining growth.

11 items

1. Executive Summary

2. Double Roller Pump Artificial Heart Lung Machine Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Double Roller Pump Artificial Heart Lung Machine Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Double Roller Pump Artificial Heart Lung Machine Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Cardiac Surgery

6.1.2. Lung Transplant Operation

6.1.3. Acute Respiratory Failure Treatment

6.1.4. Others

6.2. Global Double Roller Pump Artificial Heart Lung Machine Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Power ≤160 W

6.2.2. 160 W < Power ≤ 250 W

6.2.3. 250 W < Power ≤ 500 W

6.2.4. Power > 500 W

6.3. Global Double Roller Pump Artificial Heart Lung Machine Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Double Roller Pump Artificial Heart Lung Machine Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Double Roller Pump Artificial Heart Lung Machine Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Double Roller Pump Artificial Heart Lung Machine Market Competition by Key Manufacturers

8.1. Global Double Roller Pump Artificial Heart Lung Machine Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Double Roller Pump Artificial Heart Lung Machine: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. LivaNova (Sorin)

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Getinge (Maquet)

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Medtronic

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Terumo CV Group

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Braile Biomedica

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Tianjin Medical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Double Roller Pump Artificial Heart Lung Machine Market

Figure 4: Global Double Roller Pump Artificial Heart Lung Machine Market: Drivers

Figure 5: Global Double Roller Pump Artificial Heart Lung Machine Market: Challenges

Figure 6: Global Double Roller Pump Artificial Heart Lung Machine Market: Trends

Figure 7: Global Double Roller Pump Artificial Heart Lung Machine Market: Opportunity

Figure 8: Global Double Roller Pump Artificial Heart Lung Machine Market: Restraint

Figure 9: Global Double Roller Pump Artificial Heart Lung Machine Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Double Roller Pump Artificial Heart Lung Machine Market Value (USD Million) By Region

Figure 15: Global Double Roller Pump Artificial Heart Lung Machine Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Double Roller Pump Artificial Heart Lung Machine Market Value (USD Million) By Region

Figure 23: Global Double Roller Pump Artificial Heart Lung Machine Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

65 items

Table 1: Market Segmentation Analysis

Table 2: Global Double Roller Pump Artificial Heart Lung Machine Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Double Roller Pump Artificial Heart Lung Machine Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Double Roller Pump Artificial Heart Lung Machine Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Double Roller Pump Artificial Heart Lung Machine Market Value (USD Million) By Region

Table 10: Global Double Roller Pump Artificial Heart Lung Machine Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Double Roller Pump Artificial Heart Lung Machine Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Double Roller Pump Artificial Heart Lung Machine Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Double Roller Pump Artificial Heart Lung Machine Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: LivaNova (Sorin) Basic Information And Sales Area

Table 31: LivaNova (Sorin). Products Portfolio

Table 32: Getinge (Maquet) Basic Information And Sales Area

Table 33: Getinge (Maquet). Products Portfolio

Table 34: Medtronic Basic Information And Sales Area

Table 35: Medtronic. Products Portfolio

Table 36: Terumo CV Group Basic Information And Sales Area

Table 37: Terumo CV Group. Products Portfolio

Table 38: Braile Biomedica Basic Information And Sales Area

Table 39: Braile Biomedica. Products Portfolio

Table 40: Tianjin Medical Basic Information And Sales Area

Table 41: Tianjin Medical. Products Portfolio

Table 42: Global Market Value (USD Million) (2025-2032) By Application

Table 43: Global Market Share (%) By Application (2032)

Table 44: Global Market Value (USD Million) (2025-2032) By Types

Table 45: Global Market Share (%) By Types (2032)

Table 46: Global Double Roller Pump Artificial Heart Lung Machine Market Value (USD Million) By Region

Table 47: Global Double Roller Pump Artificial Heart Lung Machine Market Share (%) By Region (2025-2032)

Table 48: North America Market Value (USD Million) (2025-2032) By Country

Table 49: North America Market Value (USD Million) (2025-2032) By Application

Table 50: North America Market Value (USD Million) (2025-2032) By Types

Table 51: Europe Market Value (USD Million) (2025-2032) By Country

Table 52: Europe Market Value (USD Million) (2025-2032) By Application

Table 53: Europe Market Value (USD Million) (2025-2032) By Types

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 55: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 57: South America Market Value (USD Million) (2025-2032) By Country

Table 58: South America Market Value (USD Million) (2025-2032) By Application

Table 59: South America Market Value (USD Million) (2025-2032) By Types

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 61: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 63: Research Programs/Design For This Report

Table 64: Key Data Information From Secondary Sources

Table 65: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Double Roller Pump Artificial Heart Lung Machine Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	LivaNova (Sorin); Getinge (Maquet); Medtronic; Terumo CV Group; Braile Biomedica; Tianjin Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options